Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of FE 999049 in Healthy Chinese Women
NCT04150861Phase 1Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jun 2019
- Primary completion
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of follitropin delta in infertility (3 arms), sponsored by Ferring Pharmaceuticals. Primary endpoints: Area Under the Serum Concentration-time Curve From Dosing to Infinity at 9 days, Area Under the Serum Concentration-time Curve From Dosing up to Time t at 9 days and 5 more. Started Jun 2019; status: completed.
02
Drugs
follitropin delta
03
Conditions
infertility
Beyond the preview
Go deeper on NCT04150861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04150861.